for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

ICU Medical, Incorporated

ICUI.OQ

Latest Trade

159.80USD

Change

-0.20(-0.13%)

Volume

387,427

Today's Range

158.68

 - 

160.39

52 Week Range

151.01

 - 

286.45

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
160.00
Open
159.62
Volume
387,427
3M AVG Volume
4.76
Today's High
160.39
Today's Low
158.68
52 Week High
286.45
52 Week Low
151.01
Shares Out (MIL)
20.67
Market Cap (MIL)
3,306.53
Forward P/E
20.43
Dividend (Yield %)
--

Next Event

Q3 2019 ICU Medical Inc Earnings Release

Latest Developments

More

ICU Medical Q2 Adjusted Earnings Per Share $1.99

ICU Medical Q2 Adjusted Earnings Per Share $1.99

ICU Medical Says Brian Bonnell Will Be Promoted To CFO And Treasurer

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About ICU Medical, Incorporated

ICU Medical, Inc. is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company's product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems. The primary critical care products it manufactures are Hemodynamic Monitoring Systems, SafeSet Closed Blood Sampling and Conservation System, Transpac Consumable Blood Pressure Transducers and Other Critical Care Products. The primary oncology products it manufactures are ChemoLock Needlefree CSTD, ChemoClave Needlefree CSTD and Diana Hazardous Drug Compounding System. As of December 31, 2016, its products were used in acute care hospitals and ambulatory clinics in more than 65 countries throughout the world.

Industry

Medical Equipment & Supplies

Contact Info

951 Calle Amanecer

+1.949.3662183

http://www.icumed.com/

Executive Leadership

Vivek Jain

Chairman of the Board, Chief Executive Officer, Director

Scott E. Lamb

Chief Financial Officer, Treasurer

Christian B. Voigtlander

Chief Operating Officer

Virginia Sanzone

Vice President, General Counsel, Secretary

Tom L. McCall

Corporate Vice President - Marketing and Communications, General Manager - Critical Care

Key Stats

2.67 mean rating - 3 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.4K

2017

1.3K

2018

1.4K

2019(E)

1.2K
EPS (USD)

2016

4.850

2017

6.450

2018

8.840

2019(E)

7.830
Price To Earnings (TTM)
73.03
Price To Sales (TTM)
2.52
Price To Book (MRQ)
2.51
Price To Cash Flow (TTM)
26.60
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
3.54
Return on Equity (TTM)
3.02

Latest News

Smiths and ICU Medical healthcare merger talks collapse

British engineering firm Smiths Group Plc <SMIN.L> said on Thursday talks with U.S.-based ICU Medical Inc <ICUI.O> over a possible 7 billion pound-plus ($9.2 billion) merger of their healthcare businesses had fallen through.

RPT-Smiths abandons healthcare merger talks with ICU Medical

British engineering firm Smiths Group Plc has abandoned plans to combine its top medical business with U.S.-based ICU Medical Inc, the company said on Thursday, saying they were unable to agree on terms.

Smiths abandons healthcare merger talks with ICU Medical

British engineering firm Smiths Group Plc has abandoned plans to combine its top medical business with U.S.-based ICU Medical Inc, the company said on Thursday, saying they were unable to agree on terms.

Smiths rebuffs ICU's latest offer for medical division: Sky News

ICU Medical Inc's <ICUI.O> new offer to buy British engineering firm Smiths Group Plc's <SMIN.L> medical division for 2.8 billion pounds ($3.60 billion) was rejected by Smiths' board, Sky News reported on Monday.

Smiths Group, ICU Medical close to abandoning healthcare merger: Sky News

British engineering firm Smiths Group Plc <SMIN.L> is close to abandoning talks with U.S.-based ICU Medical Inc <ICUI.O> over a 7 billion pound ($9 billion) merger of their healthcare divisions, Sky News reported on Monday.

Smiths Group, ICU Medical close to abandoning healthcare merger -Sky News

British engineering firm Smiths Group Plc is close to abandoning talks with U.S.-based ICU Medical Inc about a 7 billion pound ($9 billion) merger of their healthcare divisions, Sky News reported on Monday.

Smiths Group, ICU Medical in talks about medical division merger

British engineering firm Smiths Group Plc <SMIN.L> is in very early stage discussions about a potential combination of its medical division with U.S.-based ICU Medical Inc <ICUI.O>, the British group said on Sunday.

Smiths Group, ICU Medical in talks on healthcare merger- source

British engineering firm Smiths Group Plc and U.S.-based ICU Medical Inc are in talks about a merger of their medical device businesses, a person familiar with the discussions told Reuters.

BRIEF-ICU Medical Reports Q1 Adjusted Earnings Per Share $2.26

* Q1 EARNINGS PER SHARE VIEW $1.84 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

BRIEF-ICU Medical Files For Non-Timely 10-K

* ICU MEDICAL INC FILES FOR NON-TIMELY 10-K - SEC FILING Source text : (http://bit.ly/2GUSKPV) Further company coverage:

BRIEF-ICU Medical Q4 GAAP Earnings Per Share $2.33

* ICU MEDICAL, INC. ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2017 RESULTS

BRIEF-ICU Medical Says Board Increased Size Of Board From 7 To 9

* ICU MEDICAL SAYS BOARD INCREASED SIZE OF BOARD FROM 7 TO 9 AND ELECTED DONALD ABBEY AND DAVID HOFFMEISTER AS NEW DIRECTORS - SEC FILING Source text: (http://bit.ly/2m1qvGz) Further company coverage:

BRIEF-Medical Australia says court approved ICU Medical's offer to buy co

* Federal Court of Australia approves scheme of arrangement under which ICU Medical Inc to buy all shares on issue in MLA

BRIEF-ICU Medical Q3 adjusted earnings per share $1.12

* Q3 revenue $343.2 million versus I/B/E/S view $328.6 million

BRIEF-Medical Australia enters scheme implementation agreement

* Entered scheme implementation agreement under which it is proposed that ICU Medical Inc will acquire MLA

BRIEF-ICU Medical reports Q2 loss per share $1.87

* Q2 revenue $331.5 million versus I/B/E/S view $318.3 million

BRIEF-ICU medical issues a voluntary nationwide recall of one lot of 0.9% sodium chloride injection due to the presence of particulate matter

* ICU Medical Issues a voluntary nationwide recall of one lot of 0.9% sodium chloride injection due to the presence of particulate matter

BRIEF-ICU Medical Inc says files for non-timely 10-Q

* Couldn't file 10-Q for quarter ended March as co needs additional time to properly incorporate information of Hospira Infusion Systems that co bought on Feb 3 Source text (http://bit.ly/2r4hi15) Further company coverage:

BRIEF-ICU Medical announces Q1 revenue $247.7 million

* Q1 revenue $247.7 million versus I/B/E/S view $237.1 million

BRIEF-ICU Medical receives grand jury subpoena issued by U.S. District Court

* ICU Medical- on april 18, received grand jury subpoena issued by u.s. District court for eastern district of pennsylvania - sec filing

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up